FDA QMSR Toolkit – 21 CFR Part 820 Templates

Description

What this is

The FDA QMSR Toolkit is a 73-document pack for medical device manufacturers complying with 21 CFR Part 820 as amended — the Quality Management System Regulation, effective 2 February 2026.

It is deliberately not another quality management system. Part 820 now incorporates ISO 13485:2016 by reference and adds a small, specific FDA layer on top of it. This pack documents that layer, and the FDA parts it depends on, and leaves the ISO 13485 quality management system to do the rest. If you need the quality system itself, buy the ISO 13485 Toolkit; the two are built to sit together.

Why an ISO 13485 certificate is not enough

A certificate evidences conformity with the standard. It does not evidence:

• the four bridges named in 820.10(b) — from ISO clauses to Parts 830, 821,

803 and 806;

• the design-control applicability determinations in 820.10(c) and (d);
• the seven complaint data elements and six servicing data elements in 820.35;
• the recorded UDI required by 820.35(c), as opposed to the printed one;
• the five accuracy checks and documented release in 820.45;
• the FDA definitions in 820.3 that supersede the ISO wording — including

Organization, which means manufacturer.

Those are the gaps this pack closes.

The change most quality systems have not caught up with

Under the former Quality System Regulation, section 820.180(c) exempted management review reports, internal quality audit reports and supplier audit reports from FDA review. An investigator could require only a written certification that they had been performed.

The QMSR has no section 820.180. The exemption went with it, and FDA Compliance Program 7382.850 — which replaced QSIT on the same day — lists Internal Audits and Management Review among the elements an investigator may select. Those reports can now be read.

Two documents in this pack exist solely for that change, and it is the single most common blind spot in a QSR-era quality system.

Built on the inspection program FDA actually uses

Since 2 February 2026, FDA inspects under Compliance Program 7382.850, not QSIT. It organises the quality system into 54 elements across six QMS Areas, plus 4 Other Applicable FDA Requirements, each mapped to ISO 13485 clauses and 820 sections.

Four workbooks in this pack come pre-loaded with all 54 elements and all 4 OAFRs — the evidence map, the audit checklist, the conformance register and the master cross-reference matrix. You are preparing against the same structure the investigator is working from.

What is in the pack

Section	Files
00 Programme Foundation	6
01 QSR to QMSR Transition	7
02 Quality Management System Requirement	8
03 Design and Development Applicability	6
04 Control of Records	9
05 Labeling and Packaging Controls	8
06 Cross-Referenced FDA Parts	10
07 Inspection Readiness and Evidence	12
08 Assessment and Mapping	7

73 documents — 45 Word documents and 28 Excel workbooks.

The workbooks arrive already filled in

Twelve of the 28 workbooks ship seeded rather than empty:

• All 54 QMS elements and 4 OAFRs, with their ISO 13485 clauses

and 820 sections, across four workbooks.

• All 31 sections of the old QSR, mapped to where each requirement now

lives — including the one with no successor at all.

• The four 820.10(b) bridges, each with its owning procedure.
• The seven complaint data elements and six servicing data elements as actual

columns, so a missing field is visible rather than buried in narrative.

• The five labeling accuracy checks of 820.45(a).
• The five class I device types named in 820.10(c)(2), so you can check your

portfolio against them directly.

Who it is for

• Device manufacturers marketing in the United States, at any class.
• Specification developers, contract manufacturers, relabelers, repackers and

remanufacturers — all of whom are manufacturers under 820.3(b).

• Quality and regulatory teams transitioning a QSR-era quality system.
• Organisations preparing for their first inspection under CP 7382.850.

What it does not do

It does not make you compliant, and it does not replace an ISO 13485 quality management system. It is the documented FDA layer plus the evidence structure an inspection asks for. Operating it is your work.

Currency

Written against Part 820 as amended by 89 FR 7523 (2 February 2024), corrected at 89 FR 82945 (15 October 2024), in force from 2 February 2026, and FDA Compliance Program 7382.850. ISO 13485:2016 and ISO 9000:2015 are incorporated by reference under 820.7 and are not reproduced — the pack cites clause numbers only. Those exact editions are pinned by law until FDA amends the regulation.